Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis.

Virol J · 2014 · PMC3986697 · PMID 24673792

Europe PMC DOI

hedged sentence

0.0007

closest p · 0.0× alpha

0.0007

boldest claim

The sentences

highly significantP =0.0007actually significant

The differences were highly significant at both 12 (P =0.0007) and 24 (P = 0.0115) weeks between the two groups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.